Free glutamine is unstable in parenteral solutions?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

Free glutamine is unstable in parenteral solutions?

Explanation:
Free glutamine stability in parenteral nutrition solutions is a key consideration. Free glutamine is highly unstable in aqueous PN solutions; it readily degrades via deamidation and cyclization to pyroglutamate, with increasing risk at typical PN temperatures and pH. This degradation reduces the amount of glutamine delivered and can lead to undesirable byproducts, including ammonia. To ensure reliable delivery, glutamine is supplied as a dipeptide, most commonly L-alanyl-L-glutamine, which remains stable in solution and releases glutamine upon metabolism in the body. Therefore, free glutamine being unstable in parenteral solutions is correct.

Free glutamine stability in parenteral nutrition solutions is a key consideration. Free glutamine is highly unstable in aqueous PN solutions; it readily degrades via deamidation and cyclization to pyroglutamate, with increasing risk at typical PN temperatures and pH. This degradation reduces the amount of glutamine delivered and can lead to undesirable byproducts, including ammonia. To ensure reliable delivery, glutamine is supplied as a dipeptide, most commonly L-alanyl-L-glutamine, which remains stable in solution and releases glutamine upon metabolism in the body. Therefore, free glutamine being unstable in parenteral solutions is correct.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy